Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Cash from Investing Activities (2023 - 2025)

Metagenomi (MGX) has disclosed Cash from Investing Activities for 3 consecutive years, with $32.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 13.39% to $32.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $103.5 million, a 217.44% increase, with the full-year FY2025 number at $103.5 million, up 217.44% from a year prior.
  • Cash from Investing Activities was $32.4 million for Q4 2025 at Metagenomi, up from $27.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $75.9 million in Q3 2023 to a low of -$94.7 million in Q1 2024.
  • A 3-year average of $5.1 million and a median of $21.9 million in 2025 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: tumbled 111.77% in 2024, then soared 406.28% in 2025.
  • Metagenomi's Cash from Investing Activities stood at $60.6 million in 2023, then plummeted by 52.92% to $28.5 million in 2024, then rose by 13.39% to $32.4 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Cash from Investing Activities are $32.4 million (Q4 2025), $27.4 million (Q3 2025), and $19.1 million (Q2 2025).